Restart Life Sciences Corp. Restart Life Sciences Corp.

Restart Life Sciences Corp.

HEAL

주식 순위 #35861
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
주가
$0.0497946
마지막 동기화: 2026-10-20
시가총액
$3.11M
변동 (1일)
-3.08%
변동 (1년)
73.34%
국가
CA
거래 Restart Life Sciences Corp. (HEAL)

카테고리

Healthcare
Restart Life Sciences Corp. (HEAL)의 주가 이력
최고 종가: $0.02 (2024-11-01 기준)

최저 종가: $43.29 (2006-09-01 기준)
Restart Life Sciences Corp.의 주가 이력 (2006 ~ 2026)
연간 주가 성과
연도 성과
2024 -75.42%
2023 -70.35%
2022 0.09%
2021 -76.14%
2020 34.36%
2019 -45.75%
2018 -79.87%
2017 288.11%
2016 333.30%
2015 1.17%
2014 -47.74%
2013 -50.83%
2012 -85.77%
2011 -17.65%
2010 -44.42%
2009 -3.55%
2008 -53.46%
2007 -59.30%
2006 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$527.18 23.62%
US
$251.29 835.90%
US
$137.27 -4.17%
AU
$890.85 9.42%
NL
$752.87 7.01%
CH